Annual EBITDA
$921.76M$203.00M+28.24%
Summary
- Current Value
- As of today, EXEL annual EBITDA is $921.76M, up +28.24% on
- Historical Performance
- EXEL annual EBITDA is up +314.54% over the past 3 years, up +643.17% over the past 5 years
- All-Time High Comparison
- EXEL annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual EBITDA is +368.84% above its 3-year low of $196.60M reached on
- Sector Comparison
- EXEL annual EBITDA is higher than 93.01% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $921.76M | +28.2% | +314.5% | +643.2% | +2015.9% | |
| Quarterly EBITDA | $242.86M | +41.9% | +676.4% | +769.5% | +5034.1% | |
| TTM EBITDA | $921.76M | +28.2% | +293.4% | +643.2% | +2146.6% | |
| Price | $40.74 | +6.4% | +137.6% | +91.2% | +246.7% | |
| PE Ratio | 14.63 | -15.8% | -52.1% | -86.3% | – | |
| Annual Revenue | $2.32B | +7.0% | +44.0% | +134.9% | +1153.8% | |
| Annual EPS | $2.78 | +57.7% | +394.4% | +689.9% | +426.6% | |
| $892.70M | +29.4% | +343.1% | +711.1% | +1622.0% | ||
| Annual Net Income | $782.57M | +50.1% | +329.3% | +600.1% | +947.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $921.76M | at high | |
| 5Y | $921.76M | at high | |
| All | $921.76M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $196.60M | +368.8% | |
| 5Y | $124.03M | N/A | +643.2% |
| All | -$214.97M | +528.8% |
EBITDA History
FAQ
What is the current annual EBITDA of EXEL?
As of today, EXEL annual EBITDA is $921.76M
What is 1-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +28.24% year-over-year
What is 3-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +314.54% over the past 3 years
How far is EXEL annual EBITDA from its all-time high?
EXEL annual EBITDA is currently at its all-time high
How does EXEL annual EBITDA rank versus sector peers?
EXEL annual EBITDA is higher than 93.01% of companies in Healthcare sector
When is EXEL next annual earnings release?
As of today, the next annual earnings release for EXEL has not been scheduled
Quarterly EBITDA
$242.86M$20.92M-7.93%
Summary
- Current Value
- As of today, EXEL quarterly EBITDA is $242.86M, down -7.93% on
- Historical Performance
- EXEL quarterly EBITDA is up +41.94% year-over-year, up +676.42% over the past 3 years
- All-Time High Comparison
- EXEL quarterly EBITDA is currently -14.39% below its historical high of $283.68M set on
- 3-Year Low Comparison
- EXEL quarterly EBITDA is +676.42% above its 3-year low of -$42.13M reached on an earlier date
- Sector Comparison
- EXEL quarterly EBITDA is higher than 92.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $242.86M | -7.9% | +41.9% | +676.4% | +769.5% | |
| Annual EBITDA | $921.76M | – | +28.2% | +314.5% | +643.2% | |
| TTM EBITDA | $921.76M | +8.4% | +28.2% | +293.4% | +643.2% | |
| Price | $40.74 | -8.2% | +6.4% | +137.6% | +91.2% | |
| PE Ratio | 14.63 | -8.2% | -15.8% | -52.1% | -86.3% | |
| Quarterly Revenue | $598.66M | +0.1% | +5.6% | +41.2% | +121.7% | |
| Quarterly EPS | $0.88 | +27.3% | +85.8% | +1048.5% | +896.5% | |
| $235.91M | -8.0% | +44.3% | +590.7% | +870.9% | ||
| Quarterly Net Income | $244.53M | +26.3% | +74.8% | +910.4% | +761.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $263.78M | -7.9% | |
| 3Y | $283.68M | -14.4% | |
| 5Y | $283.68M | -14.4% | |
| All | $283.68M | -14.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $194.20M | N/A | +25.1% |
| 3Y | -$42.13M | N/A | +676.4% |
| 5Y | -$42.13M | +676.4% | |
| All | -$64.44M | +476.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of EXEL?
As of today, EXEL quarterly EBITDA is $242.86M
What is EXEL quarterly EBITDA most recent change?
EXEL quarterly EBITDA was down -7.93% on December 1, 2025
What is 1-year change in EXEL quarterly EBITDA?
EXEL quarterly EBITDA is up +41.94% year-over-year
How far is EXEL quarterly EBITDA from its all-time high?
EXEL quarterly EBITDA is currently -14.39% below its historical high of $283.68M set on June 28, 2024
How does EXEL quarterly EBITDA rank versus sector peers?
EXEL quarterly EBITDA is higher than 92.79% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM EBITDA
$921.76M$71.75M+8.44%
Summary
- Current Value
- As of today, EXEL TTM EBITDA is $921.76M, up +8.44% on
- Historical Performance
- EXEL TTM EBITDA is up +28.24% year-over-year, up +293.43% over the past 3 years
- All-Time High Comparison
- EXEL TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL TTM EBITDA is +1050.24% above its 3-year low of $80.14M reached on
- Sector Comparison
- EXEL TTM EBITDA is higher than 92.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $921.76M | +8.4% | +28.2% | +293.4% | +643.2% | |
| Annual EBITDA | $921.76M | – | +28.2% | +314.5% | +643.2% | |
| Quarterly EBITDA | $242.86M | -7.9% | +41.9% | +676.4% | +769.5% | |
| Price | $40.74 | -8.2% | +6.4% | +137.6% | +91.2% | |
| PE Ratio | 14.63 | -8.2% | -15.8% | -52.1% | -86.3% | |
| TTM Revenue | $2.32B | +1.4% | +7.0% | +44.0% | +134.9% | |
| TTM EPS | $2.78 | +17.2% | +57.1% | +395.8% | +697.4% | |
| $892.70M | +8.8% | +29.4% | +343.1% | +711.1% | ||
| TTM Net Income | $782.57M | +15.4% | +50.1% | +329.3% | +600.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $921.76M | at high | |
| 3Y | $921.76M | at high | |
| 5Y | $921.76M | at high | |
| All | $921.76M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $781.52M | +17.9% | |
| 3Y | $80.14M | +1050.2% | |
| 5Y | $67.71M | N/A | +1261.3% |
| All | -$238.61M | +486.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of EXEL?
As of today, EXEL TTM EBITDA is $921.76M
What is EXEL TTM EBITDA most recent change?
EXEL TTM EBITDA was up +8.44% on December 1, 2025
What is 1-year change in EXEL TTM EBITDA?
EXEL TTM EBITDA is up +28.24% year-over-year
How far is EXEL TTM EBITDA from its all-time high?
EXEL TTM EBITDA is currently at its all-time high
How does EXEL TTM EBITDA rank versus sector peers?
EXEL TTM EBITDA is higher than 92.88% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- EXEL Official Website www.exelixis.com
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel